PAREXEL International Announces Date of Fourth Quarter and Fiscal Year 2014 Earnings Release and Conference Call
Boston, MA, July 10, 2014 – PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Fourth Quarter and Fiscal Year 2014 on Wednesday, August 6th, 2014 after the close of the stock market. The announcement will be available on PAREXEL’s website at www.PAREXEL.com and on the PRNewswire website at www.prnewswire.com.
PAREXEL will host a conference call and live webcast at 10:00 a.m. EDT on Thursday, August 7th, 2014 to discuss the results. To access the webcast, visit PAREXEL’s website at www.PAREXEL.com, and click on the Investors menu. This webcast will continue to be accessible for one year following the live broadcast. To participate via telephone, dial (408) 940-3886 and ask to join PAREXEL’s Fourth Quarter and Fiscal Year 2014 conference call.
About PAREXEL International
PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. PAREXEL Informatics provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 75 locations in 50 countries around the world, and has 15,335 employees. For more information about PAREXEL International visit www.PAREXEL.com.
PAREXEL, PAREXEL Informatics, Perceptive, Perceptive MyTrials, and “Your Journey. Our Mission.” are trademarks or registered trademarks of PAREXEL International Corporation or its affiliates.